Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Chronic Liver Disease New Targets And New Mechanisms PDF full book. Access full book title Chronic Liver Disease New Targets And New Mechanisms.
| Author | : Jinhang Gao |
| Publisher | : Frontiers Media SA |
| Total Pages | : 186 |
| Release | : 2022-08-16 |
| Genre | : Science |
| ISBN | : 2889767760 |
| Author | : Gianfranco Danilo Alpini |
| Publisher | : Frontiers Media SA |
| Total Pages | : 279 |
| Release | : 2022-01-25 |
| Genre | : Medical |
| ISBN | : 2889741567 |
| Author | : Pere Ginès |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 583 |
| Release | : 2010-11-03 |
| Genre | : Medical |
| ISBN | : 1607618664 |
Chronic liver failure is a frequent condition in clinical practice that encompasses all manifestations of patients with end-stage liver diseases. Chronic liver failure is a multiorgan syndrome that affects the liver, kidneys, brain, heart, lungs, adrenal glands, and vascular, coagulation, and immune systems. Chronic Liver Failure: Mechanisms and Management covers for the first time all aspects of chronic liver failure in a single book, from pathogenesis to current management. Each chapter is written by a worldwide known expert in their area and all provide the latest state-of-the-art knowledge. This volume is specifically designed to provide answers to clinical questions to all doctors dealing with patients with liver diseases, not only clinical gastroenterologists and hepatologists, but also to internists, nephrologists, intensive care physicians, and transplant surgeons.
| Author | : Pablo Muriel |
| Publisher | : Academic Press |
| Total Pages | : 276 |
| Release | : 2022-04-23 |
| Genre | : Science |
| ISBN | : 0323952895 |
Hepatic Fibrosis: Mechanisms and Targets is a complete volume of liver extracellular matrix biology, including molecular signaling pathways, cells and factors that modulate fibrogenesis and fibrosis. The book uses an integrated approach toward the molecular and cellular mechanisms involved in the synthesis and degradation of hepatic fibrotic tissue, emphasizing the possible molecular targets to fight fibrosis. This important reference describes, in detail and didactically, the cellular and molecular events that are conducive to fibrosis that leads to cirrhosis, hepatocellular carcinoma and death. The provided information allows readers to understand the molecular mechanisms of hepatic fibrogenesis to accelerate the development of new therapies. Presents progression from inflammation to fibrosis, with a special focus on the molecular mechanisms involved Didactically explains the participation of cells, cytokines and factors in profibrogenic pathways Illuminates the causative participation of free radicals in liver fibrogenesis Explains the role of gut dysbiosis in chronic liver diseases leading to fibrosis Provides experimental models to study liver fibrosis and describes available, noninvasive monitoring methods
| Author | : Shakir Ali |
| Publisher | : |
| Total Pages | : 328 |
| Release | : 2006 |
| Genre | : Liver |
| ISBN | : |
Twenty-nine articles by a richly international group of specialists offer new insights into many areas of liver disease. The first volume contains articles on mediators and regulation of liver disease and the immunological basis of liver injury, with individual topics that include the role of chemokines in liver pathophysiology, the basis for immune recognition of cellular targets in primary biliary cirrhosis, and the role of nitric oxide in liver disorders. Volume Two contains articles on pathophysiology, therapy, and diagnosis and includes chapters on molecular virology and therapeutic targets for the Hepatitis C virus, and new therapeutic approaches for hepatic fibrosis. The three editors are Ali (biochemistry, Deemed U., New Delhi, India), Scott L. Friedman (division of liver diseases, Mount Sinai School of Medicine, New York), and Derek A. Mann (molecular biology, Southampton U. Hospital, UK). Distributed in the US by Enfield. Annotation :2006 Book News, Inc., Portland, OR (booknews.com).
| Author | : Baoming Wu |
| Publisher | : Frontiers Media SA |
| Total Pages | : 129 |
| Release | : 2023-01-11 |
| Genre | : Science |
| ISBN | : 2832511341 |
| Author | : |
| Publisher | : Academic Press |
| Total Pages | : 288 |
| Release | : 2019-07-13 |
| Genre | : Medical |
| ISBN | : 0128173173 |
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series
| Author | : Neil Kaplowitz |
| Publisher | : CRC Press |
| Total Pages | : 790 |
| Release | : 2002-10-16 |
| Genre | : Medical |
| ISBN | : 0203909127 |
Featuring more than 4100 references, Drug-Induced Liver Disease will be an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines.
| Author | : Elizabeth J. Carey |
| Publisher | : Springer |
| Total Pages | : 265 |
| Release | : 2014-07-18 |
| Genre | : Medical |
| ISBN | : 1493910132 |
Since the publication of the first edition, there have been advances in both the diagnosis and the management of many of the cholestatic liver diseases. Cholestatic Liver Disease, Second Edition thoroughly updates the topics previously addressed, such as primary biliary cirrhosis, primary sclerosing cholangitis and cholestatic variants of drug hepatotoxicity and viral disease. New treatments, such as the development of the farnesoid X receptor agonists for the treatment of PBC, are highlighted. Current guidelines and areas of uncertainty are also covered. Additionally, new chapters have been added to reflect the changing landscape of cholestatic liver disease. Cholestatic Liver Disease, Second Edition is a concise yet comprehensive summary of the current status of the field and is of value to clinicians and researchers interested in patients with cholestatic liver disease provide that will help to guide patient management and stimulate investigative efforts.
| Author | : Shao Li |
| Publisher | : Springer Nature |
| Total Pages | : 480 |
| Release | : 2021-09-29 |
| Genre | : Medical |
| ISBN | : 9811607532 |
This book introduces “network pharmacology” as an emerging frontier subject of systematic drug research in the era of artificial intelligence and big data. Network Pharmacology is an original subject of fusion system biology, bioinformatics, network science and other related disciplines. It emphasizes on starting from the overall perspective of the system level and biological networks, the analysis of the laws of molecular association between drugs and their treatment objects, reveals the systematic pharmacological mechanisms of drugs, and guides the research and development of new drugs and clinical diagnosis and treatment. After it was proposed, network pharmacology has been paid attention by researchers, and it has been rapidly developed and widely used. In order to systematically reveal the biological basis of diagnosis and treatment in traditional Chinese medicine and modern medicine, we proposed a new concept of "network target" for the first time, which has become the core theory of "network pharmacology". The core principle of a network target is to construct a biological network that can be used to decipher complex diseases. The network is then used as the therapeutic target, to which multicomponent remedies are applied. This book mainly includes four parts: 1) The concept and theory of network pharmacology; 2) Common analysis methods, databases and software in network pharmacological research; 3) Typical cases of traditional Chinese medicine modernization and modern drug research based on network pharmacology; 4) Network pharmacology practice process based on drugs and diseases.
